Guardian Pharmacy Services (NYSE:GRDN) Shares Up 5.4% - What's Next?

Key Points

• Guardian Pharmacy Services shares rose 5.4% to about $39.11, with approximately 329,000 shares changing hands.
• Analyst sentiment remains positive: eight analysts rate the stock a Buy and one rates it a Hold, with a consensus “Moderate Buy” rating and an average price target of $43.83.
• The company exceeded quarterly expectations, reporting $0.29 in earnings per share versus the $0.26 estimate and revenue of $351.77 million compared with the $340.45 million consensus.

Guardian Pharmacy Services, Inc. (NYSE:GRDN - Get Free Report) shares traded up 5.4% during trading on Tuesday . The company traded as high as $39.34 and last traded at $39.11. Approximately 328,979 shares traded hands during mid-day trading, a decline of 15% from the average daily volume of 386,244 shares. The stock had previously closed at $37.09.

Analysts Set New Price Targets

GRDN has been the subject of a number of recent research reports. Bank of America boosted their target price on Guardian Pharmacy Services from $42.00 to $47.00 and gave the stock a "buy" rating in a research report on Wednesday, June 17th. Wall Street Zen upgraded Guardian Pharmacy Services from a "hold" rating to a "buy" rating in a report on Sunday, August 9th. Zacks Research lowered Guardian Pharmacy Services from a "strong-buy" rating to a "hold" rating in a research report on Monday, May 11th. Oppenheimer boosted their price objective on Guardian Pharmacy Services from $43.00 to $49.00 and gave the stock an "outperform" rating in a report on Friday, August 7th. Finally, Truist Financial upped their target price on shares of Guardian Pharmacy Services from $43.00 to $47.00 and gave the company a "buy" rating in a research report on Wednesday, June 17th. Eight research analysts have rated the stock with a Buy rating and one has given a Hold rating to the stock. According to data from MarketBeat, Guardian Pharmacy Services currently has a consensus rating of "Moderate Buy" and an average target price of $43.83.

Guardian Pharmacy Services Trading Up 5.0%

The business's fifty day simple moving average is $39.79 and its 200 day simple moving average is $37.93. The stock has a market cap of $1.94 billion, a price-to-earnings ratio of 37.83, a price-to-earnings-growth ratio of 1.92 and a beta of 0.11.

Guardian Pharmacy Services (NYSE:GRDN - Get Free Report) last posted its quarterly earnings results on Thursday, August 6th. The company reported $0.29 earnings per share for the quarter, beating analysts' consensus estimates of $0.26 by $0.03. Guardian Pharmacy Services had a return on equity of 29.97% and a net margin of 4.50%.The company had revenue of $351.77 million for the quarter, compared to the consensus estimate of $340.45 million. As a group, research analysts anticipate that Guardian Pharmacy Services, Inc. will post 1.19 earnings per share for the current year.

Hedge Funds Weigh In On Guardian Pharmacy Services

Several hedge funds have recently added to or reduced their stakes in GRDN. California State Teachers Retirement System grew its position in shares of Guardian Pharmacy Services by 7,848.6% during the 2nd quarter. California State Teachers Retirement System now owns 1,415,960 shares of the company's stock worth $59,286,000 after buying an additional 1,398,146 shares during the period. Valiant Capital Management L.P. raised its position in shares of Guardian Pharmacy Services by 15.8% in the 4th quarter. Valiant Capital Management L.P. now owns 1,232,463 shares of the company's stock valued at $37,085,000 after acquiring an additional 167,741 shares during the period. Wellington Management Group LLP boosted its stake in Guardian Pharmacy Services by 3.3% during the 3rd quarter. Wellington Management Group LLP now owns 1,143,729 shares of the company's stock worth $30,000,000 after acquiring an additional 36,072 shares during the last quarter. Franklin Resources Inc. boosted its stake in Guardian Pharmacy Services by 8.2% during the 3rd quarter. Franklin Resources Inc. now owns 1,056,240 shares of the company's stock worth $27,705,000 after acquiring an additional 80,033 shares during the last quarter. Finally, Vanguard Group Inc. grew its holdings in Guardian Pharmacy Services by 9.1% during the third quarter. Vanguard Group Inc. now owns 1,055,102 shares of the company's stock valued at $27,675,000 after purchasing an additional 88,296 shares during the period.

About Guardian Pharmacy Services

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes. The company's Guardian Compass includes dashboards created using data from its data warehouse to help its local pharmacies plan, track, and optimize their business operations; and GuardianShield Programs for LTCFs.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source